First outcomes of the EU JAMS 2.0 project - Joint Action on Reinforced Market Surveillance for Medical Devices

JAMS 2.0 is a Joint Action co-funded by the European Union under the EU4Health programme involving 24 EU Member States. The goal is to reinforce the market surveillance for medical devices and in vitro diagnostic devices and to foster cooperation between National Competent Authorities (NCAs). The project started in November 2023 and runs for 36 months with several activities across 8 technical and operational work packages.

For more information and the first project outcomes, see here.